Inventaire - prietenii tai și comunicațiile sunt cea mai buna librărie - Inventaire

Citează articole 99

Dată

Title

Autori

2020-10-12

Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest

William R Hartman
2020-09-15

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Sean T H Liu, Allen Zheng, Freddy T Nguyen, Daniel Stadlbauer, Deena R Altman, Florian Krammer, Matthew A Levin, Judith Aberg, Nicole M. Bouvier, Fatima Amanat, Arturo Casadevall, David L. Reich, Damodara Rao Mendu, Jeffrey S Jhang, Ian Baine, Suzanne Arinsburg, Carlos Cordon-Cardo
2020-09-01

The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq
2020-09-02

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

James Logue, Nita K. Patel, Gale Smith, Cheryl Keech
2020-08-13

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Mariano A Garcia-Blanco, Xuping Xie, Pei-Yong Shi
2020-08-11

Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein

Marc C Johnson, Clifton L Ricana, Terri D. Lyddon
2020-08-03

Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection
2020-07-03

A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition

Liise-anne Pirofski, Gorka Lasso, Kartik Chandran
2020-07-03

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Paul W Rothlauf, Zhuoming Liu, Herbert W. Virgin, Daved H. Fremont
2020-07-21

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
2020-07-23

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Vivian Chih-Wei Chen, Barnaby Young, Wan Rong Sia, Danielle E Anderson, Lin-Fa Wang
2020-07-20

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Merryn Voysey, Amy Flaxman, Daniel Jenkin, Duncan Bellamy, Angela Minassian, Pedro M Folegatti, Katrina Pollock, Alexander D Douglas, Saul N Faust, Adrian V. S. Hill, Paul Heath, Andrew Pollard, Katie J. Ewer, Teresa Lambe, Sarah Gilbert, Matthew D Snape, Elizabeth A. Clutterbuck, Brian J Angus, Parvinder Kaur Aley, Sandra Belij-Rammerstorfer, Sagida Bibi, Christina Dold, Adam Finn, Bassam Hallis, Rajeka Lazarus, Rebecca Makinson, Oxford COVID Vaccine Trial Group
2020-07-22

Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike

Manoj S Nair, Gabriele Cerutti, Jason Gorman, Tongqing Zhou, Zhiwei Chen, Yuen Kwok-yung, Yaoxing Huang, Lawrence Shapiro, David D Ho, Peter D. Kwong, Micah A Rapp, Jude Bimela, Joseph Sodroski, Zizhang Sheng, Vincent Sahi, Amir Figueroa, Xinzheng V Guo
2020-11-01

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

Fabian Schmidt, Yiska Weisblum, Christian Gaebler, Charles M. Rice, Hans-Heinrich Hoffmann, Paul Bieniasz
2020-07-15

Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes

Toni L Meister, Adalbert Krawczyk, Philip V'kovski, Daniel Todt, Stephanie Pfaender, Gert Zimmer
2020-07-14

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

Lisa A Jackson, Nicole Doria-Rose, John H. Beigel, Andrea J. Pruijssers, Mark R. Denison, Kizzmekia Corbett, James David Chappell, Barney S. Graham, Evan J. Anderson, Nadine Rouphael, Mamodikoe Makhene, Rhea N Coler, Adrian B. McDermott, John R. Mascola, Kaitlyn M Morabito, Kathleen Neuzil, Julie Ledgerwood, Laura J. Stevens, Stephen D Schmidt, Britta Flach, Sijy O'Dell, Phillip A Swanson, Marcelino Padilla, Mat Makowski, Kaitlyn Cross, mRNA-1273 Study Group
2020-06-25

Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results
2020-06-22

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Xiangyang Chi, Renhong Yan, Jun Zhang, Guanying Zhang, Yuanyuan Zhang, Meng Hao, Zhe Zhang, Pengfei Fan, Yunzhu Dong, Yilong Yang, Zhengshan Chen, Yingying Guo, Jinlong Zhang, Yaning Li, Xiaohong Song, Yi Chen, Lu Xia, Ling Fu, Lihua Hou, Junjie Xu, Changming Yu, Jianmin Li, Qiang Zhou, Wei Chen
2020-06-08

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Michael Boeckh, Janet Englund, Julie McElrath
2020-06-18

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Quanxin Long, Hai-Jun Deng, Yong Zhang, Jing-Fu Qiu, Juan Chen, Ailong Huang, XiaoJun Tang, Xia-Mao Liu
2020-06-15

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F Rogers, Fangzhu Zhao, Deli Huang, Nathan A. Beutler, Wan-Ting He, Oliver Limbo, Chloe Smith, Ge Song, Jordan Woehl, Linlin Yang, Robert K Abbott, Jonathan Hurtado, Sydney I Ramirez, Michael J Ricciardi, Nicholas C Wu, Meng Yuan, Davey Smith, David Nemazee, John R Teijaro, James E Voss, Ian A Wilson, Bryan Briney, Elise Landais, Devin Sok, Joseph G Jardine, Dennis R. Burton
2020-06-15

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Anna Z Wec, Daniel Wrapp, Andrew S Herbert, Denise Haslwanter, Rohit K Jangra, María Dieterle, Asparouh Lilov, Deli Huang, Longping V Tse, Nicole V Johnson, Nianshuang Wang, Juergen H Nett, Michael E. Brown, Shu Lin, Robert H. Bortz, Ariel S Wirchnianski, Catalina Florez, Jens Maximilian Fels, Cecilia M O'Brien, Barney S. Graham, David Nemazee, Dennis R. Burton, Ralph S. Baric, James E Voss, John M Dye, Jason S McLellan, Laura M Walker, Mrunal Sakharkar, Irina Burnina, Melanie Sinclair, Sarat Pudi, Ethan Laudermilch, Kartik Chandran
2020-06-11

Early safety indicators of COVID-19 convalescent plasma in 5,000 patients

Arturo Casadevall
2020-06-03

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial
2020-05-29

SARS-CoV-2 Antibody Testing - Questions to be asked
2020-05-27

Treatment of COVID-19 Patients with Convalescent Plasma

Eric Salazar, Brian Castillo
2020-05-27

Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence

Nicasio Mancini
2020-05-22

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
2020-05-20

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Abishek Chandrashekar, Jinyan Liu, Amanda J Martinot, Katherine McMahan, Noe B. Mercado, Lauren Peter, Lisa H Tostanoski, Jingyou Yu, Zoltan Maliga, Kathleen Busman-Sahay, Margaret Terry, Linda M Wrijil, Sarah Ducat, Caroline Atyeo, Stephanie Fischinger, John S Burke, Matthew Slein, Laurent Pessaint, Alex Van Ry, Jack Greenhouse, Tammy Taylor, Kelvin Blade, Brad Finneyfrock, Roland Zahn, Frank Wegmann, Peter Abbink, Esther A. Bondzie, Gabriel Dagotto, Makda S Gebre, Catherine Jacob-Dolan, Nicole Kordana, Michelle A Lifton, Shant H Mahrokhian, Lori F Maxfield, Ramya Nityanandam, Joseph P. Nkolola, Aaron G Schmidt, Andrew D Miller, Ralph S. Baric, Galit Alter, Peter K. Sorger, Jacob D Estes, Hanne Andersen, Mark G. Lewis, Dan H. Barouch
2020-05-20

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection

Wendy Barclay
2020-05-03

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
2020-05-12

Identification of Human Single-Domain Antibodies against SARS-CoV-2

Articol - wd:Q98577501

Bun Venit la Inventaire!

the library of your friends and communities

Ești offline